Cancer Research UK logo.
SearchDonate
  • Search

A trial comparing treatment approaches for prostate cancer (ProtecT)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 3

Details

This trial was done to compare 3 treatment options for prostate cancer that is contained within the prostate gland. This is called localised cancer.

The treatment options were radiotherapy, surgery and active monitoring. The trial was done because doctors weren’t sure if any one treatment was better than another for men in this situation.

It was open for people to join between 1999 and 2009. The team published long term results in 2023.

Recruitment start: 1 October 2001

Recruitment end: 20 January 2009

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor FC Hamdy

Professor JL Donovan

Professor DE Neal

Supported by

NIHR Health Technology Assessment (HTA) programme

University of Oxford

University of Bristol

University of Cambridge

Cancer Research UK

NIHR Oxford Biomedical Research Centre

NIHR CLAHRC West

Other information

You can read more on the ProtecT trial website.

Last reviewed: 09 May 2023

CRUK internal database number: 117

Help and support